Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK)

Historical Holders from Q3 2024 to Q3 2025

Symbol
EVOK on Nasdaq
CUSIP
30049G302
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
1.55M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
591K
Holdings value
$2.94M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
15
Number of buys
11
Number of sells
-3
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 15.99% $1.33M 268K Nantahala Capital Management, LLC Nov 3, 2025
MORGAN STANLEY 10.5% $866K 164K Morgan Stanley Aug 31, 2025
Klein Roger M. 10.5% $810K 163K Klein Roger M. Nov 4, 2025
LYTTON LAURENCE W 3.9% $138K 61.3K Lytton, Laurence W. Mar 31, 2025

Institutional Holders of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 591K $2.94M +$1.81M $4.97 15
2025 Q2 232K $604K -$26.8K $2.60 10
2025 Q1 242K $666K +$63.2K $2.75 9
2024 Q4 218K $966K +$13.3K $4.42 8
2024 Q3 208K $995K +$994K $4.76 11